205 related articles for article (PubMed ID: 26384350)
1. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
[TBL] [Abstract][Full Text] [Related]
2. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation.
Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G
Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA HOXA-AS2 promotes migration and invasion by acting as a ceRNA of miR-520c-3p in osteosarcoma cells.
Wang Y; Zhang R; Cheng G; Xu R; Han X
Cell Cycle; 2018; 17(13):1637-1648. PubMed ID: 30081707
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection induces gastric cancer cell malignancy by targeting HOXA-AS2/miR-509-3p/MMD2 axis.
Cheng S; Jia Y; Wu J; Li J; Cao Y
Genes Genomics; 2024 Jun; 46(6):647-657. PubMed ID: 38573409
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
Chen R; He P
J Pharm Pharmacol; 2021 Sep; 73(10):1387-1396. PubMed ID: 34240204
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA HOXA-AS2 Facilitates Prostate Cancer Progression by Inhibiting miR-885-5p to Upregulate KDM5B.
Yang Z; Zhang F; Cai K; Xu J
Kidney Blood Press Res; 2023; 48(1):45-55. PubMed ID: 36404720
[TBL] [Abstract][Full Text] [Related]
8. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA
Gao K; Lv A; Zhang Q; Li Y; Yue Z; Xu S
Allergol Immunopathol (Madr); 2023; 51(2):36-44. PubMed ID: 36916086
[TBL] [Abstract][Full Text] [Related]
10. BOP1 Silencing Suppresses Gastric Cancer Proliferation through p53 Modulation.
Yang YP; Qin RH; Zhao JJ; Qin XY
Curr Med Sci; 2021 Apr; 41(2):287-296. PubMed ID: 33877544
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic and clinicopathological significance of HOXA-AS2 in human cancers: a systematic review and meta-analysis.
Lu B; Liu Z; Ji X; Zhang X
Transl Cancer Res; 2023 Mar; 12(3):605-615. PubMed ID: 37033343
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
J Exp Clin Cancer Res; 2018 Jan; 37(1):13. PubMed ID: 29374493
[TBL] [Abstract][Full Text] [Related]
13. HOXA-AS2 Epigenetically Inhibits HBV Transcription by Recruiting the MTA1-HDAC1/2 Deacetylase Complex to cccDNA Minichromosome.
Qin Y; Ren J; Yu H; He X; Cheng S; Chen W; Yang Z; Sun F; Wang C; Yuan S; Chen P; Wu D; Ren F; Huang A; Chen J
Adv Sci (Weinh); 2024 Apr; ():e2306810. PubMed ID: 38647380
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis.
Wang Q; Zhang W; Deng C; Lin S; Zhou Y
Front Oncol; 2022; 12():1030825. PubMed ID: 36387249
[TBL] [Abstract][Full Text] [Related]
15. Effects of Long Noncoding RNA HOXA-AS2 on the Proliferation and Migration of Gallbladder Cancer Cells.
Zhang P; Liu L; Zhang W; Fang J; Li G; Zhang L; Li J; Deng X; Ma J; Li K; Chen Z
J Oncol; 2022; 2022():6051512. PubMed ID: 36299503
[TBL] [Abstract][Full Text] [Related]
16. HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis.
Zhang F; Zhang G; Zhang H; Pu X; Chi F; Zhang D; Xin X; Gao M; Luo W; Li X
Front Genet; 2022; 13():944278. PubMed ID: 36437956
[No Abstract] [Full Text] [Related]
17. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.
Jin Y; Cao J; Cheng H; Hu X
J Chemother; 2023 Nov; 35(7):638-652. PubMed ID: 36797828
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.
Xiao T; Yan A; Tan L; Zhu H; Gao W
Oncol Lett; 2024 May; 27(5):226. PubMed ID: 38586205
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of
Soghala S; Harsiny K; Momeni P; Hatami M; Kholghi Oskooei V; Hussen BM; Taheri M; Ghafouri-Fard S
Heliyon; 2022 Oct; 8(10):e11155. PubMed ID: 36299522
[TBL] [Abstract][Full Text] [Related]
20. MyoD1 promotes the transcription of BIK and plays an apoptosis-promoting role in the development of gastric cancer.
Wu F; Zhang J; Jiang Q; Li Q; Li F; Li J; Lv W; Wang X; Qin Y; Huang C; Zhang S
Cell Cycle; 2024 Mar; 23(5):573-587. PubMed ID: 38701194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]